LBA330 months relapse-free survival, overall survival, and...

Annals of Oncology 2018 / 12 Vol. 29; Iss. suppl_10

LBA330 months relapse-free survival, overall survival, and long-term toxicity update of (neo)adjuvant ipilimumab (ipi) + nivolumab (nivo) in macroscopic stage III melanoma (OPACIN trial)

Rozeman, E A, Sikorska, K, van de Wiel, B A, Fanchi, L F, Krijgsman, O, van Thienen, H V, Pronk, L M, Broeks, A, Grijpink-Ongering, L, Ter Meulen, S, Bruining, A, Klop, W M C, van Tinteren, H, Peeper,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy511.002
Date:
December, 2018
File:
PDF, 90 KB
english, 2018
Conversion to is in progress
Conversion to is failed